Source: Annual Congress 2010 - Novel markers of lung injury
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Samara, E. Neofytou, A. Karatzanis, D. Papandrinopoulou, V. Tzilas, G. Tsoukalas, N. Siafakas, E. Tzortzaki (Heraklion Crete, Greece). Cytotoxicity molecules expression in COPD patients with acquired somatic DNA mutations. Eur Respir J 2010; 36: Suppl. 54, 1804

Member's Comments

No comment yet.

Related content which might interest you: DNA methylation and gene expression changes in human lung fibroblasts occur already in mild COPD and progress with disease development Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Evaluation of mRNA expression profiling of NF-?B mediated signaling in COPD patients. Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 Differential gene expression in primary bronchial epithelial cells from COPD patients and control subjects. Evaluation by means of a cDNA array for cytokines and cytokine related genes Source: Eur Respir J 2002; 20: Suppl. 38, 483s Year: 2002 LSC 2010 Abstract: Perforin expression in COPD patients with microsatellite DNA instability Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Loss of heterozygosity detected in plasma DNA of early stage lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 673s Year: 2004 Circulating miRNAs from imprinted genomic regions are associated with peripheral muscle strength in COPD patients Source: Eur Respir J , 49 (4)  1601881; DOI: 10.1183/13993003.01881-2016 Year: 2017 Epigenetic changes are associated with altered hBD-1 gene expression in patients with COPD Source: Annual Congress 2008 - Cell biology of asthma and COPD Year: 2008 Recognition of aberrant promoter methylation for early diagnosis of lung cancer patients Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020 Identifying the sputum and BALF cell subpopulation with somatic DNA alterations in COPD Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009 Expression of selected surface markers on macrophages in induced sputum from patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 Microarray gene expression profiles in lung tissue of COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 537s Year: 2007 Very early detection of small clones harbouring EGFR mutations in NSCLC by 2nd generation sequencing Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Polymorphisms in the p53 and p21 promoter are associated with susceptibility to COPD Source: Eur Respir J 2005; 26: Suppl. 49, 52s Year: 2005 Expression of apoptotic markers in lung tissue of COPD patients: preliminary results Source: Eur Respir J 2006; 28: Suppl. 50, 748s Year: 2006 Altered DNA methylation levels in the context of exposures and respiratory disease Source: International Congress 2016 – Genetics, epigenetics and the exposome Year: 2016 DNA methylation is associated with lung function levels in never-smokers Source: International Congress 2017 – Epigenetics of lung function Year: 2017 Phenotype and outcome of PAH patients carrying a TBX4 mutation Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension Year: 2020 Characteristics and prognostic relevance of p53 gene mutations in Polish non small cell lung cancer (NSCLC) patients Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005 Phenotype pattern of human non-small cell lung cancer (NSCLC) model line in immune escape phenomenon. Effect of transfection with plasmids encoding specific anti-EGFR1 and anti-HER2/neu short hairpin (SH)RNA sequences Source: Annual Congress 2009 - Basic science and lung cancer Year: 2009